Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.

Abstract : Red blood cell transfusions have reduced morbidity and mortality for patients with sickle cell disease. Transfusions can lead to erythrocyte alloimmunization, however, with serious complications for the patient including life-threatening delayed hemolytic transfusion reactions and difficulty in finding compatible units, which can cause transfusion delays. In this review, we discuss the risk factors associated with alloimmunization with emphasis on possible mechanisms that can trigger delayed hemolytic transfusion reactions in sickle cell disease, and we describe the challenges in transfusion management of these patients, including opportunities and emerging approaches for minimizing this life-threatening complication.
Type de document :
Article dans des revues
Blood, American Society of Hematology, 2012, 120 (3), pp.528-37. <10.1182/blood-2011-11-327361>


http://www.hal.inserm.fr/inserm-00696264
Contributeur : Georges Guellaen <>
Soumis le : dimanche 11 novembre 2012 - 07:00:00
Dernière modification le : dimanche 11 novembre 2012 - 07:00:00

Identifiants

Collections

Citation

Karina Yazdanbakhsh, Russell Ware, France Noizat-Pirenne. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.. Blood, American Society of Hematology, 2012, 120 (3), pp.528-37. <10.1182/blood-2011-11-327361>. <inserm-00696264>

Exporter

Partager

Métriques